• Endothelial SGK1 and Vascular Stiffening

  2026-10-05

  Zhang and colleagues identify endothelial SGK1 as a mechanistic link between mineralocorticoid and salt-sensitive signaling, actin remodeling, and vascular stiffening. Genetic deletion and pharmacological inhibition produced convergent evidence across mouse, ex vivo, and human endothelial-cell models, while the findings remain preclinical and do not establish clinical efficacy.

• γH2AX DNA Damage Detection: Five Evidence Questions

  2026-10-05

  A source-grounded guide to what γ-H2AX immunofluorescence can show, how strong the current FLASH-RT evidence is, and where interpretation must remain cautious.

• Medroxyprogesterone Acetate: Receptor to Translation

  2026-10-04

  A thought-leadership analysis of Medroxyprogesterone acetate as a context-dependent research tool, connecting progesterone signaling with endometrial lipid metabolism, renal epithelial biology, neurobiology, and translational study design.

• E-64d: Interpreting Protease-Driven Cell States

  2026-10-03

  E-64d is a membrane-permeable cysteine protease inhibitor whose broad intracellular activity can help frame causal questions in apoptosis, platelet biology, neuroprotection, and cancer research. This article connects its pharmacology with new findings on GA-driven autophagic degradation of DELLA proteins while defining the limits of cross-system interpretation.

• Sumatriptan’s Anti-Inflammatory Evidence

  2026-10-01

  This systematic review reframes Sumatriptan Succinate as more than an acute migraine medicine by integrating evidence for cytokine, NF-κB, nitric oxide, caspase, and CGRP regulation across inflammatory injury models. Its main practical value is hypothesis generation: receptor-centered experiments can test whether 5-HT1B/1D signaling contributes to tissue protection beyond trigeminovascular effects.

• Homoharringtonine: Mechanism and Research Evidence

  2026-10-01

  Homoharringtonine is a cytotoxic alkaloid and protein synthesis inhibitor used in leukemia research and cancer biology. Peer-reviewed evidence also supports SARS-CoV-2 antiviral research, but antiviral findings remain distinct from an approved self-treatment or a validated clinical protocol.

• Vitamin D/VDR Control of Endometrial Decidualization

  2026-09-30

  This study shows that active vitamin D promotes human endometrial stromal cell decidualization through VDR-dependent regulation of CYP19, ESR1, and the local estrogen environment. Its combination of time-course analysis, VDR perturbation, primary-cell validation, and ChIP-qPCR provides a mechanistic framework for understanding how vitamin D status may influence endometrial receptivity.

• Acifran Workflows for HCAR Lipid Signaling

  2026-09-30

  Build reproducible HCAR2/HCAR3 experiments with Acifran by linking receptor activation to cAMP and lipid-metabolism phenotypes. This workflow emphasizes matched receptor controls, solvent discipline, and structure-informed interpretation rather than assuming that one agonist produces identical signaling in every cell context.

• Bafilomycin A1: Designing Better Mitophagy Assays

  2026-09-29

  Bafilomycin A1 is a powerful V-ATPase inhibitor, but interpreting mitophagy experiments requires separating increased autophagic cargo from impaired lysosomal clearance. This guide connects its pharmacology with the BipD–KLHL9/KLHL13/CUL3–IMMT pathway in bacterial infection and provides an assay-focused workflow.

• HotStart™ 2X Green qPCR Master Mix Guide

  2026-09-29

  This practical guide explains how HotStart™ 2X Green qPCR Master Mix supports SYBR Green detection for cDNA and DNA quantification while reducing nonspecific amplification risks associated with reaction setup. It is appropriate for real-time PCR gene expression analysis, RNA-seq validation, and nucleic acid quantification, but it should not be treated as a direct RNA assay or used without instrument- and target-specific validation.

• Meropenem Workflows for Infection Research

  2026-09-28

  Meropenem supports controlled antibacterial, cell-culture, and Gram-negative infection-model experiments when concentration, solvent, and resistance context are documented. This guide converts its PBP-directed activity into reproducible workflows while showing where broad activity should not be confused with efficacy against carbapenem-resistant isolates.

• ATRX Loss Sensitizes High-Grade Glioma to RTK Inhibitors

  2026-09-28

  A 2022 drug-screening study found that ATRX-deficient high-grade glioma cells were more sensitive to several receptor tyrosine kinase and PDGFR inhibitors than comparator cells. The reported increase in cellular toxicity with temozolomide combinations supports testing ATRX status as a stratification variable in preclinical studies and in analyses of relevant clinical trials, while leaving clinical benefit unproven.

• WP1066: JAK2/STAT3 Inhibitor Research Guide

  2026-09-27

  WP1066 is a cell-permeable JAK2/STAT3 inhibitor used to investigate phosphorylation-dependent signaling and cancer-cell responses. Product information describes activity in renal carcinoma and leukemia models, but its inhibitory action must not be conflated with studies in which JAK2/STAT3 activation supports macrophage-mediated bone repair.

• Camptothecin Disrupts FUBP1–FUSE DNA Binding

  2026-09-26

  A drug-library screen identified camptothecin and SN-38 as inhibitors of FUBP1 binding to its single-stranded DNA target, FUSE. The study links this biochemical effect to altered FUBP1 target-gene expression in hepatocellular carcinoma cells, suggesting a possible mechanism alongside topoisomerase I inhibition—not proof of clinical benefit through FUBP1.

• Bestatin Reveals New Layers of Jasmonate Signaling

  2026-09-25

  The study positions bestatin as a chemical-genetic probe for jasmonate signaling: it activates jasmonate-responsive genes and developmental responses, with gene induction requiring COI1-dependent signaling but not strict dependence on jasmonate biosynthesis. Screening for bestatin-resistant Arabidopsis mutants then separated defects in bestatin response from distinct changes in jasmonate sensitivity, providing a route to identify additional pathway components.

8660 records 1/578 page Next 12345 下5页 Last page